In NSCLC patients with initial treatment , squamous carcinoma and phase III , there were significant differences in ORR and DCR between the groups ( P < 0.05 ) , while ORR was significant in patients with adenocarcinoma , GP/TP and in phase IIIa ( P < 0.05 ) .